Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Hakan Kardes Sells 10,500 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hakan Kardes sold 10,500 shares of the firm’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $14.99, for a total value of $157,395.00. Following the sale, the insider now owns 309,944 shares in the company, valued at $4,646,060.56. This trade represents a 3.28 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Hakan Kardes also recently made the following trade(s):

• On Wednesday, November 27th, Hakan Kardes sold 35,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.80, for a total value of $448,000.00.
• On Monday, November 4th, Hakan Kardes sold 20,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.06, for a total value of $267,730.00.
• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.98, for a total transaction of $58,410.00.

Alignment Healthcare Stock Performance

Alignment Healthcare stock opened at $14.57 on Friday. The firm has a market capitalization of $2.79 billion, a PE ratio of -18.92 and a beta of 1.45. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $15.03. The stock’s 50 day moving average price is $12.06 and its 200 day moving average price is $10.94. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60.

Alignment Healthcare (NASDAQ:ALHC) last posted its earnings results on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, hitting analysts’ consensus estimates of ($0.14). The business had revenue of $692.43 million for the quarter, compared to analysts’ expectations of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The business’s revenue for the quarter was up 51.6% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.19) earnings per share. As a group, sell-side analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently commented on ALHC. Barclays upped their price target on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 30th. Stifel Nicolaus upped their price objective on Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Tuesday, January 14th. UBS Group increased their target price on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 30th. Stephens reissued an “overweight” rating and set a $17.00 price target on shares of Alignment Healthcare in a research report on Thursday, January 2nd. Finally, KeyCorp assumed coverage on Alignment Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $11.88.

Hedge Funds Weigh In On Alignment Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. R Squared Ltd acquired a new position in shares of Alignment Healthcare in the fourth quarter worth about $55,000. nVerses Capital LLC purchased a new stake in Alignment Healthcare during the 3rd quarter worth approximately $95,000. Ballentine Partners LLC acquired a new position in shares of Alignment Healthcare in the 4th quarter valued at approximately $121,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Alignment Healthcare during the 3rd quarter valued at approximately $131,000. Finally, Creative Planning grew its position in shares of Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company’s stock worth $147,000 after buying an additional 2,072 shares in the last quarter. 86.19% of the stock is owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.